[82] As a glucagon-like peptide-1 receptor agonist, semaglutide suppresses the release of glucagon by the liver which in turn lowers blood pressure
If you experience significant side effects, you can stay at your current dose for an extra 24 weeks
If they advise using it, ask about expected potency and whether you should watch for signs of reduced effectiveness
There's also, obviously, advancements in biotech that are in phase two and phase three trials that have next-generation GLP-1, GIP dual and triagonists." Talks about a partnership deal with Novo Nordisk "clears months of uncertainty around the partnership and opens a clearer path for Hims weight loss vertical, one of the companys core growth drivers," Ethan Feller, stock strategist at Zacks Investment Research, said in written commentary
Article 2 mins The Aon Difference How Aon is moving further, faster to bring new, innovative solutions that address companies risk and people challenges